New treatments for congestive heart failure Help
Heart disease is one of the worst murderers in the world to date. Failure heart failure, a condition that is secondary to many major heart disease, has its own type of mortality. Fifty percent of patients diagnosed with congestive heart failure die within five years. Scientists and researchers have always had trouble understand the exact mechanisms of the disease, and to find a cure.
Congestive heart failure begins when the heart cells die or stop functioning attributable to an event like a myocardial infarction (heart attack) or ischemic heart disease. Whatever the cause, the heart is pumping blood subsequently ineffective throughout the body, resulting in the accumulation of blood in the organs and the fluid accumulating in and around the lungs such as sodium can not be excreted properly, causing dyspnea, which is the classic symptom of congestive heart failure.
Clinical research is being conducted by treatment of the disease and the possibility of repairing damaged cells in the heart. Current research is underway to measure the new drugs lend a hand in vasodilation, as well as an inhibitor of calcium producethe no higher incidence of cardiac arrhythmias seen with the drugs currently on the market.
In the era of medical resources, the power of the mind has been invoked in clinical trials to apply meditation and relaxation techniques combat stress on the heart may be the turning point for patients with congestive heart failure. Stress has been shown to affect negatively body's blood pressure forcing the heart to work harder and put too much strain on a weak muscle in that time.
The theory lies in the belief that learning to maintain a low level of mental stress, the heart will be less stressed and as a result less likely to fail completely, and the patient be accorded be a better prognosis.
Along with the return to natural disasters, holistic treatment methods is an incredible breakthrough in the Medical technology was not available twenty or thirty years in the past. Scientists say they've identified a set of altered genes that can cause a more prone to suffer from congestive heart failure and are using their current experience of the genes and the benefits of gene therapy in an effort reverse the effect. In addition, drugs to tamp down on the actions of genes, such as beta blockers and alpha-2 agonists are currently available and being used treatment programs.
Also being explored is the possibility of using stem cells to help in the repair of damaged heart tissue. Clinical trials showed that patients at risk of congestive heart failure responded favorably to an injection of your own stem cells in the heart, and while the exact means by which the causes of this improvement is still unknown. It is suspected that these cells either to facilitate the growth of new vessels in the heart or act as a kind of beacon that attracts the very healing of body cells to the site of damage and stimulate repair.
The ability to grow healthy tissue the human embryonic stem cells for transplantation is also being studied, although the controversial nature of the use of human embryonic stem cells because the mandatory destruction of the embryo makes it unlikely in the foreseeable future. Scientists have determined that adult stem cells can not provide a supply appropriate new cells to meet the needs of patients who suffered from congestive heart failure.
Congestive heart failure is incredibly dangerous to the extent that the body can not play dead tissue cells in the heart anyway, with modern advances, is the desire of researchers everywhere one day find a cure.
About the Author
Mark has suffered with a congestive heart problem since 1994 and is now severely disabled. He now maintains a website for anyone who wants information on congestive heart problems.
More informative articles on Heart Disease are available here
Forex Video | Trading Tip | Advanced Price Action
|
|
Advanced Cardiovascular Update- DVD 1 $65.00 Congestive Heart Failure Topics Moderators: Jerry D. Estep, M.D., FACC George P. Noon, M.D. LVAD George P. Noon, M.D. Revascularization Studies Dipan J. Shah, M.D., FACC Bi-V Pacing Jerry D. Estep, M.D., FACC Case 1: EP Perspective Timothy K. Doyle, M.D., FACC Case 2: Surgical Perspective Scott Scheinin, M.D. Question & Answer... |
|
|
Drug Treatment of Heart Failure $1.38 ... |
|
|
Resynchronization Pacing Yields Benefits in Advanced Heart Failure.(Brief Article): An article from: Family Practice News $5.95 This digital document is an article from Family Practice News, published by International Medical News Group on April 15, 2001. The length of the article is 621 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation De... |
|
|
Panel Backs Device for Advanced Heart Failure.: An article from: Internal Medicine News $5.95 This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2001. The length of the article is 982 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... |